AMP
43
2
CAT
47
3
AN
49
2
EW
55
5
IRM
33
5
HSIC
42
2
PEG
53
7
WFC
58
8
PFG
27
7
TXN
29
4
SPG
45
2
DFS
64
4
MCD
52
3
SNA
56
3
FAST
41
7
CME
59
3
PYPL
49
4
AMT
30
2
ADT
12
2
VIX
41
-11
AMP
43
2
CAT
47
3
AN
49
2
EW
55
5
IRM
33
5
HSIC
42
2
PEG
53
7
WFC
58
8
PFG
27
7
TXN
29
4
SPG
45
2
DFS
64
4
MCD
52
3
SNA
56
3
FAST
41
7
CME
59
3
PYPL
49
4
AMT
30
2
ADT
12
2
VIX
41
-11
Financhill
Back

First Trust Nasdaq Pharmaceuticals ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37

FTXH
First Trust Nasdaq Pharmaceuticals ETF

Last Price:
$27.05
Seasonality Move:
-1.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

First Trust Nasdaq Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, First Trust Nasdaq Pharmaceuticals ETF has on average historically risen by 5.1% based on the past 8 years of stock performance.
  • First Trust Nasdaq Pharmaceuticals ETF has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is First Trust Nasdaq Pharmaceuticals ETF Stock Undervalued?
    The current First Trust Nasdaq Pharmaceuticals ETF [FTXH] share price is $26.98. The Score for FTXH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • FTXH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will First Trust Nasdaq Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, First Trust Nasdaq Pharmaceuticals ETF has on average historically risen by 5.1% based on the past 8 years of stock performance.

First Trust Nasdaq Pharmaceuticals ETF Stock Rating

Sell
37
First Trust Nasdaq Pharmaceuticals ETF (FTXH) is a Sell

Is First Trust Nasdaq Pharmaceuticals ETF overpriced?

  • First Trust Nasdaq Pharmaceuticals ETF has risen higher in 6 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

First Trust Nasdaq Pharmaceuticals ETF Stock Price History

Is FTXH stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTXH is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
29.72
52-Week Low:
25.73

Prediction Charts

Market Cap:
0
Price in USD:
26.98
Volume:
2K
Beta:
0.75

Technical Analysis

SMA50:
28.13
SMA100:
28.49
SMA200:
27.84
52-Wk Change:
4%

Stock Predictions

  • Is First Trust Nasdaq Pharmaceuticals ETF stock public?
    Yes, First Trust Nasdaq Pharmaceuticals ETF is a publicly traded company.
  • What is the First Trust Nasdaq Pharmaceuticals ETF stock quote today?
    The First Trust Nasdaq Pharmaceuticals ETF stock price is 26.98 USD today.
  • How to buy First Trust Nasdaq Pharmaceuticals ETF stock online?
    You can buy First Trust Nasdaq Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 28.16 28.38 28.39 28.16
Dec-3 28.34 28.15 28.36 28.16
Dec-4 28.09 28.17 28.20 28.09
Dec-5 28.12 28.08 28.15 28.10
Dec-6 28.12 28.10 28.14 28.07
Dec-9 28.16 28.10 28.22 28.16
Dec-10 27.79 27.83 27.98 27.79
Dec-11 27.69 27.70 27.78 27.69
Dec-12 27.76 27.59 27.76 27.73
Dec-16 27.53 27.26 27.53 27.25
Dec-17 27.49 27.50 27.50 27.49
Dec-18 27.38 26.83 27.40 27.25
Dec-19 26.66 26.74 26.84 26.65
Dec-20 26.93 26.98 27.05 26.89

First Trust Nasdaq Pharmaceuticals ETF Earnings

Data Unavailable

First Trust Nasdaq Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* First Trust Nasdaq Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.